BXTAccelyon Blog

January 28, 2020

“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now

A new ‘Open Access’ perspective paper by Grummet, J., Gorin, M.A., Popert, R. et al. as published in Springer Nature’s Prostate Cancer and Prostatic Diseases, is calling for the full, global eradication of the transrectal (TRUS) prostate biopsy to transperineal (TP) biopsy under local anaesthetic to be instigated in 2020.

The authors assert that “a well-planned global ‘TRexit’ with a phase-out period of TR biopsy led by centres experienced in TP biopsy, should be […] aiming for completion by the end of 2022.”

Curre...

Please reload

  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon
  • Black YouTube Icon
Featured Posts

BXTAccelyon and Hitachi Medical Systems to support #TRexit

As the national campaign to eradicate traditional transrectal (TRUS) biopsies from the prost...

BXTAccelyon and Hitachi Medical Systems to support #TRexit

February 11, 2020

1/10